Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ASRT	ASSERTIO HOLDINGS INC	$71.70M	-38.20%	-15.40%	-28.43%	-48.10%	1.93	1.59	67.90%	-37.00%	-34.30%
NIVF	NEWGENIVF GROUP LTD	$168.05k	N/A	N/A	N/A	N/A	0.65	2.21	N/A	N/A	N/A
ADVB	ADVANCED BIOMED INC	$9.95M	-139.90%	-54.80%	-89.95%	398.80%	0.87	2.09	N/A	N/A	N/A
AKRO	AKERO THERAPEUTICS INC	$4.31B	-32.00%	-29.40%	-23.77%	-42.40%	0.07	16.80	N/A	N/A	N/A
MLSS	MILESTONE SCIENTIFIC INC	$32.99M	-133.80%	-73.20%	-162.83%	-225.70%	1.41	2.03	72.80%	-76.80%	-76.78%
NDRA	ENDRA LIFE SCIENCES INC	$3.89M	-283.00%	-186.40%	-392.88%	-398.60%	0.91	3.21	N/A	N/A	N/A
AIM	AIM IMMUNOTECH INC	$5.44M	N/A	-198.50%	248.39%	683.60%	-1.63	0.10	71.10%	-13,360.30%	-12,858.68%
AHG	AKSO HEALTH GROUP	$882.09M	-80.00%	-75.60%	-82.42%	-557.00%	0.08	14.20	-1.90%	-913.40%	-1,121.81%
NRXS	NEURAXIS INC	$26.42M	-652.30%	-194.90%	-149.54%	689.90%	0.67	2.82	84.80%	-242.60%	-220.34%
IKT	INHIBIKASE THERAPEUTICS INC	$119.23M	-63.80%	-58.00%	-51.85%	-319.40%	0.11	10.09	N/A	N/A	N/A
IMCC	IM CANNABIS CORP	$5.62M	-22.50%	-2.70%	84.06%	49.40%	10.51	0.72	24.20%	-2.20%	9.50%
MYNZ	MAINZ BIOMED NV	$5.99M	N/A	-207.80%	-508.89%	-2,883.90%	2.89	0.52	67.50%	-2,874.70%	-2,942.01%
BRTX	BIORESTORATIVE THERAPIES INC	$11.97M	-145.30%	-93.90%	-221.32%	-192.50%	0.76	2.07	94.50%	-1,771.90%	-1,771.91%
KTTA	PASITHEA THERAPEUTICS CORP	$6.07M	-88.60%	-81.10%	-88.11%	4,718.40%	0.12	4.97	N/A	N/A	N/A
MURA	MURAL ONCOLOGY PLC	$36.21M	-122.30%	-99.40%	-248.83%	-582.70%	0.49	2.87	N/A	N/A	N/A
MTVA	METAVIA INC	$24.20M	-212.00%	-107.20%	-191.84%	239.50%	0.92	2.08	N/A	N/A	N/A
CNSP	CNS PHARMACEUTICALS INC	$4.12M	-183.90%	-139.40%	-117.66%	1,437.20%	0.11	10.22	N/A	N/A	N/A
ACON	ACLARION INC	$4.56M	-84.40%	-77.30%	-48.78%	2,399.00%	0.04	23.81	-26.40%	-11,215.90%	-10,996.43%
COCH	ENVOY MEDICAL INC	$16.44M	N/A	-273.70%	-1,026.26%	-101.80%	-1.33	0.94	-262.20%	-12,704.50%	-8,783.33%
CODX	CO-DIAGNOSTICS INC	$15.56M	-69.50%	-60.50%	-84.09%	-155.10%	0.13	4.13	39.60%	-3,586.00%	-3,582.18%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$6.82M	-210.20%	-138.40%	-204.24%	-295.00%	0.49	4.07	N/A	N/A	N/A
MRUS	MERUS NV	$7.19B	-53.30%	-44.90%	-49.01%	-90.10%	0.17	7.97	100.00%	-546.30%	-574.26%
CHEK	CHECK-CAP LTD	$7.84M	-226.20%	-198.10%	1,809.55%	-390.80%	-1.26	0.15	N/A	N/A	N/A
ADIL	ADIAL PHARMACEUTICALS INC	$7.53M	-191.30%	-153.60%	-151.14%	-8,040.80%	0.22	5.02	N/A	N/A	N/A
IXHL	INCANNEX HEALTHCARE INC	$123.09M	-661.50%	-294.00%	-346.00%	-1,347.30%	0.53	2.86	100.00%	-54,517.40%	-54,165.12%
MOVE	MOVANO INC	$4.63M	-219.60%	-152.70%	-994.59%	-8,772.20%	2.46	1.35	-414.00%	-4,302.10%	-4,302.13%
JAGX	JAGUAR HEALTH INC	$4.02M	-530.10%	-76.80%	-215.16%	-107.80%	5.18	0.96	81.90%	-344.20%	-347.06%
EVGN	EVOGENE LTD	$10.98M	N/A	-38.50%	-53.84%	-87.80%	-14.85	1.89	13.90%	-385.20%	-272.59%
MOLN	MOLECULAR PARTNERS AG	$152.75M	-51.00%	-44.90%	-55.21%	-116.80%	0.17	9.28	N/A	N/A	N/A
EVO	EVOTEC SE	$1.43B	-16.90%	-8.10%	-8.51%	-8.40%	1.14	1.58	12.90%	-20.00%	-15.61%
MNOV	MEDICINOVA INC	$73.57M	-23.10%	-21.80%	-25.03%	-318.90%	0.06	13.26	13.60%	-8,775.80%	-8,771.68%
MLEC	MOOLEC SCIENCE SA	$2.60M	-150.90%	-26.60%	-25.84%	-22.10%	10.22	1.48	-8.20%	-105.70%	-82.22%
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	$7.21M	5.90%	5.00%	7.91%	8.70%	0.16	5.71	34.30%	10.40%	14.57%
ADGM	ADAGIO MEDICAL HOLDINGS INC	$16.77M	-222.60%	-112.40%	-203.07%	-361.10%	3.14	2.50	-841.30%	-24,320.80%	-23,396.28%
FONR	FONAR CORP	$98.92M	4.60%	3.70%	5.74%	6.50%	0.33	8.45	41.10%	7.50%	10.99%
GDTC	CYTOMED THERAPEUTICS LTD	$24.41M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$7.08M	-48.30%	-43.00%	-45.36%	-78.30%	0.12	8.71	N/A	N/A	N/A
JUNS	JUPITER NEUROSCIENCES INC	$45.98M	-835.30%	-155.10%	-429.83%	975.20%	1.96	1.07	N/A	N/A	N/A
HSCS	HEARTSCIENCES INC	$7.76M	-383.30%	-145.30%	-236.86%	-737.30%	1.05	1.47	57.80%	-140,296.50%	-129,710.70%
MBIO	MUSTANG BIO INC	$6.09M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
AVDL	AVADEL PHARMACEUTICALS PLC	$1.84B	-3.70%	-1.70%	3.28%	4.70%	1.06	2.79	89.60%	-1.30%	1.93%
LPTX	LEAP THERAPEUTICS INC	$17.36M	-237.60%	-155.40%	-1,138.48%	485.50%	2.51	1.34	N/A	N/A	N/A
LYRA	LYRA THERAPEUTICS INC	$9.46M	-412.00%	-61.20%	-93.74%	-75.60%	31.41	2.78	100.00%	-5,043.60%	-5,041.17%
PCSA	PROCESSA PHARMACEUTICALS INC	$18.63M	-342.40%	-243.50%	-210.93%	-3,727.00%	0.34	3.45	N/A	N/A	N/A
LFWD	LIFEWARD LTD	$9.14M	-137.90%	-90.30%	-181.00%	-408.10%	0.77	2.00	35.60%	-121.80%	-121.63%
NXGL	NEXGEL INC	$18.96M	-57.50%	-28.00%	-38.88%	-38.00%	1.00	1.74	38.60%	-25.00%	-24.37%
PIII	P3 HEALTH PARTNERS INC	$63.54M	-192.00%	-18.60%	-48.64%	81.00%	14.49	0.31	-8.00%	-10.00%	-7.54%
SRXH	SRX HEALTH SOLUTIONS INC	$7.61M	N/A	-78.20%	41.92%	-386.40%	-1.74	0.33	34.80%	-43.30%	-45.29%
LNSR	LENSAR INC	$147.40M	-777.70%	-86.20%	-123.60%	-176.80%	-3.67	1.81	47.90%	-99.20%	-99.16%
MTSR	METSERA INC	$6.38B	N/A	N/A	N/A	N/A	0.42	5.26	N/A	N/A	N/A
ADAG	ADAGENE INC	$84.36M	-63.30%	-35.70%	-76.75%	184.60%	0.76	2.29	100.00%	-28,961.70%	-28,260.68%
ATHE	ALTERITY THERAPEUTICS LTD	$73.57M	-43.20%	-37.20%	-28.43%	-222.50%	0.09	12.98	100.00%	-159.00%	-158.08%
VYNE	VYNE THERAPEUTICS INC	$8.81M	-77.60%	-63.10%	-99.12%	-137.10%	0.15	7.60	100.00%	-8,097.70%	-8,096.85%
VTAK	CATHETER PRECISION INC	$2.95M	-245.00%	-91.80%	-82.39%	4,791.10%	2.80	0.44	92.30%	-4,010.00%	-2,872.67%
CERO	CERO THERAPEUTICS HOLDINGS INC	$145.85k	N/A	-623.40%	995.62%	382.90%	-4.80	0.56	N/A	N/A	N/A
INAB	IN8BIO INC	$8.53M	-183.10%	-125.50%	-137.16%	-226.60%	0.27	7.03	N/A	N/A	N/A
PLUR	PLURI INC	$30.10M	N/A	-63.40%	-338.46%	-45.60%	-5.78	0.68	49.00%	-1,690.30%	-1,609.96%
LVTX	LAVA THERAPEUTICS NV	$42.88M	-106.60%	-38.40%	-49.09%	-82.60%	2.04	10.78	100.00%	-568.80%	-540.42%
CCM	CONCORD MEDICAL SERVICES HOLDINGS LTD	$23.79M	N/A	-0.10%	6.46%	3.90%	-2.24	0.42	144.20%	-1.10%	47.29%
IRIX	IRIDEX CORP	$18.18M	-187.30%	-17.40%	-30.22%	-39.50%	4.21	1.96	39.50%	-11.00%	-10.86%
SNSE	SENSEI BIOTHERAPEUTICS INC	$10.86M	-74.80%	-63.60%	-95.89%	-96.30%	0.16	7.64	N/A	N/A	N/A
TELA	TELA BIO INC	$54.27M	-329.50%	-57.30%	-73.83%	-63.50%	6.35	3.19	67.30%	-54.10%	-47.52%
SBFM	SUNSHINE BIOPHARMA INC	$7.79M	-26.00%	-20.70%	-24.48%	-50.70%	0.25	5.00	33.30%	-17.40%	-17.78%
EMPG	EMPRO GROUP INC	N/A	69.70%	19.70%	54.59%	42.70%	4.10	1.45	61.80%	13.70%	20.11%
CMND	CLEARMIND MEDICINE INC	$4.36M	-173.80%	-70.50%	-364.89%	138.60%	2.73	1.32	N/A	N/A	N/A
EDAP	EDAP TMS SA	$74.41M	-57.60%	-27.30%	-61.10%	-78.70%	1.46	1.51	42.50%	-33.30%	-33.19%
YCBD	CBDMD INC	$7.50M	-184.40%	-45.20%	-24.47%	-253.70%	0.62	N/A	61.20%	-25.50%	-8.12%
VNRX	VOLITIONRX LTD	$47.34M	N/A	-237.40%	4,275.56%	8,595.30%	-1.31	0.35	100.00%	-1,767.90%	-1,737.41%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$218.99M	-123.50%	-118.40%	-138.38%	13,065.60%	0.12	8.72	N/A	N/A	N/A
VRAX	VIRAX BIOLABS GROUP LTD	$2.35M	-109.60%	-101.80%	-108.73%	-324.80%	0.17	7.27	-838.20%	-95,739.20%	-98,816.73%
EUDA	EUDA HEALTH HOLDINGS LTD	$88.06M	-5.50%	12.90%	-8.50%	-10.90%	-1.58	0.23	22.40%	5.20%	5.90%
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$175.15M	-2,898.10%	-117.30%	-144.31%	-1,076.10%	45.01	4.04	54.50%	-1,489.70%	-1,487.01%
VIVS	VIVOSIM LABS INC	$6.14M	-33.00%	-21.40%	-20.06%	-143.80%	0.26	4.52	97.90%	-1,399.30%	-1,389.44%
DYAI	DYADIC INTERNATIONAL INC	$39.08M	-355.30%	-60.70%	-113.79%	-79.20%	-16.36	2.02	59.90%	-134.80%	-123.19%
SMLR	SEMLER SCIENTIFIC INC	$376.19M	17.20%	12.90%	9.62%	15.40%	0.36	0.60	90.80%	86.20%	108.74%
VANI	VIVANI MEDICAL INC	$94.79M	-194.70%	-68.60%	-115.09%	-76.80%	4.89	1.30	N/A	N/A	N/A
ENVB	ENVERIC BIOSCIENCES INC	$1.92M	-341.50%	-240.70%	-454.80%	4,067.80%	0.62	2.43	N/A	N/A	N/A
IBO	IMPACT BIOMEDICAL INC	$6.49M	-528.70%	-145.10%	907.95%	-2,020.30%	-2.56	0.06	-57.10%	-549,628.60%	-533,357.14%
WORX	SCWORX CORP	$2.24M	-60.00%	-45.00%	-22.94%	111.40%	0.22	0.68	21.40%	-105.80%	-44.11%
FORA	FORIAN INC	$69.38M	-3.10%	-1.80%	-1.31%	-1.10%	0.57	2.66	59.30%	-3.60%	-1.62%
RNA	AVIDITY BIOSCIENCES INC	$8.41B	-27.00%	-24.60%	-26.87%	-34.70%	0.10	16.91	100.00%	-4,136.00%	-4,136.00%
CSBR	CHAMPIONS ONCOLOGY INC	$93.76M	87.90%	9.90%	36.58%	36.90%	7.70	0.93	48.50%	5.20%	5.05%
NERV	MINERVA NEUROSCIENCES INC	$26.71M	-41.40%	31.40%	40.26%	19.40%	-1.95	6.15	N/A	N/A	N/A
CLSD	CLEARSIDE BIOMEDICAL INC	$21.41M	N/A	-124.10%	-219.76%	-47.60%	-1.32	3.87	70.50%	-2,061.90%	-2,008.71%
CUE	CUE BIOPHARMA INC	$55.18M	-230.10%	-111.20%	-178.91%	-2,975.80%	1.24	1.60	100.00%	-469.30%	-463.15%
BGM	BGM GROUP LTD	$69.63M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
CV	CAPSOVISION INC	$223.58M	N/A	N/A	N/A	N/A	-0.04	1.85	N/A	N/A	N/A
CYCN	CYCLERION THERAPEUTICS INC	$6.21M	-22.60%	-20.70%	-22.71%	-36.00%	0.09	5.03	100.00%	-89.50%	-89.51%
BYSI	BEYONDSPRING INC	$83.49M	N/A	-4.60%	-5.45%	-11.50%	-1.61	2.19	100.00%	119.00%	105.20%
DRMA	DERMATA THERAPEUTICS INC	$2.33M	-215.00%	-153.80%	N/A	-3,035.10%	0.18	N/A	N/A	N/A	N/A
RADX	RADIOPHARM THERANOSTICS LTD	$34.62M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
PMCB	PHARMACYTE BIOTECH INC	$6.23M	-12.50%	-11.20%	-2.55%	-3.80%	0.04	18.01	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$4.81M	-54.50%	-47.30%	-69.28%	3,722.20%	0.20	5.93	100.00%	-126.00%	-126.03%
CTSO	CYTOSORBENTS CORP	$48.90M	-114.40%	-31.80%	-37.84%	-28.70%	2.49	2.61	71.70%	-45.90%	-44.98%
XBIT	XBIOTECH INC	$69.82M	-15.60%	-14.60%	-15.81%	-130.50%	0.03	40.16	N/A	N/A	N/A
TXMD	THERAPEUTICSMD INC	$13.31M	-1.70%	-1.20%	-1.55%	-1.80%	0.41	2.89	100.00%	-17.90%	-20.44%
POAI	PREDICTIVE ONCOLOGY INC	$5.98M	N/A	-179.60%	2,384.36%	-598.90%	-3.08	0.32	48.50%	-913.60%	-913.57%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	624	-2.06%	-1.34%	+3.14%	-59.24%	-14.60x	4.93x	-98.94%	-9.17%	-18.86%	+63.01%	Strong Buy
Diagnostics & Research	56	+1.34%	+0.63%	+6.47%	+9.44%	22.59x	4.27x	-3.19%	+6.95%	+14.77%	+2.61%	Strong Buy
Drug Manufacturers - General	20	+0.75%	+1.84%	+0.33%	+4.20%	35.10x	6.27x	+65.09%	+11.83%	+19.69%	+6.64%	Buy
Drug Manufacturers - Specialty & Generic	77	-0.50%	-1.29%	-1.12%	-19.53%	-5.95x	2.20x	+10.36%	+4.20%	+9.67%	+35.92%	Strong Buy
Healthcare Plans	10	-0.18%	-8.92%	-10.86%	-26.85%	43.36x	2.03x	+12.48%	+3.87%	+9.42%	+21.13%	Buy
Health Information Services	55	+0.43%	-1.94%	+2.27%	-52.78%	66.02x	4.57x	-39.16%	-0.68%	+3.56%	+23.05%	Strong Buy
Medical Care Facilities	49	+0.94%	-1.63%	+1.32%	-21.77%	16.57x	5.25x	-80.96%	+7.16%	+16.40%	+15.88%	Buy
Medical Devices	139	+0.16%	-3.42%	-2.41%	-36.20%	26.08x	3.84x	+11.78%	+8.00%	+9.89%	+29.98%	Strong Buy
Medical Distribution	11	+0.86%	+2.73%	+11.72%	+46.38%	31.82x	560.36x	-11.56%	+3.14%	+19.08%	+4.50%	Buy
Medical Instruments & Supplies	56	-0.06%	-3.72%	-0.95%	-50.21%	37.64x	3.55x	+11.10%	+9.08%	+12.37%	+22.10%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #1 top healthcare stock out of 1097 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 27, which is 2 points higher than the healthcare sector average of 25. It passed 8 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 239.87% over the past year, overperforming other healthcare stocks by 281 percentage points.

Indivior has an average 1 year price target of $32.50, an upside of 4.17% from Indivior's current stock price of $31.20.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1097 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: B.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 10 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 33.12% over the past year, overperforming other healthcare stocks by 74 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $13.50, an upside of 20.59% from Amneal Pharmaceuticals's current stock price of $11.20.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #3 top healthcare stock out of 1097 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -7.7% over the past year, overperforming other healthcare stocks by 33 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 37.85% from Embecta's current stock price of $13.42.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.71%, which is 12 percentage points higher than the healthcare sector average of 2.2%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 36% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 11.09%, which is 9 percentage points higher than the healthcare sector average of 2.2%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.99%, which is 7 percentage points higher than the healthcare sector average of 2.2%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.33% in the last day, and down -1.47% over the last week. Uniqure Nv was the among the top losers in the healthcare sector, dropping -49.34% yesterday.

uniQure shares are trading lower after HC Wainwright lowered its price target on the stock from $110 to $70. Also, William Blair downgraded the stock from Outperform to Market Perform.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -11.26% in the past year. It has overperformed other stocks in the healthcare sector by 30 percentage points.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -26.46% in the past year. It has overperformed other stocks in the healthcare sector by 15 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -15.3% in the past year. It has overperformed other stocks in the healthcare sector by 26 percentage points.

Are healthcare stocks a good buy now?

54.67% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 31.59% over the next year.

6.81% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.01% of healthcare stocks are rated B (Buy), 45.96% are rated C (Hold), 24.94% are rated D (Sell), and 10.28% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 24.59x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Indivior (NASDAQ:INDV)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Embecta (NASDAQ:EMBC)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Bausch Health Companies (NYSE:BHC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Indivior (NASDAQ:INDV)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Embecta (NASDAQ:EMBC)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Bausch Health Companies (NYSE:BHC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.